No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / genetics
-
Breast Neoplasms / metabolism*
-
Breast Neoplasms / pathology
-
Carcinoma / diagnosis*
-
Carcinoma / genetics
-
Carcinoma / metabolism*
-
Carcinoma / pathology
-
Female
-
Gene Amplification / physiology
-
Gene Frequency
-
Humans
-
In Situ Hybridization, Fluorescence / statistics & numerical data*
-
Molecular Targeted Therapy / methods
-
Molecular Targeted Therapy / statistics & numerical data
-
Monitoring, Physiologic / methods
-
Neoplasm Invasiveness
-
Prognosis
-
Receptor, ErbB-2 / antagonists & inhibitors
-
Receptor, ErbB-2 / genetics
-
Receptor, ErbB-2 / metabolism*
-
Trastuzumab
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Trastuzumab